insights_auto
Why is ORX down 5.32%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEKÂ 1.32
arrow_downward
-5.32%(-0.074) 1D
Nov 6, 5:11:11 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 1.47
High
SEKÂ 1.47
Low
SEKÂ 1.31
Mkt. cap
46.23M
Avg. vol.
320.60K
Volume
493.61K
P/E ratio
0.06
52-wk high
SEKÂ 36.00
52-wk low
SEKÂ 1.30
EPS
SEKÂ 21.73
Shares outstanding
35.13M
No. of employees
55
Open
SEKÂ 1.47
High
SEKÂ 1.47
Low
SEKÂ 1.31
Mkt. cap
46.23M
Avg. vol.
320.60K
Volume
493.61K
P/E ratio
0.06
52-wk high
SEKÂ 36.00
52-wk low
SEKÂ 1.30
EPS
SEKÂ 21.73
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
qz.com
·
31 minutes ago
Stock futures explained: how Dow, S&P 500 and Nasdaq-100 contracts work
UA.NEWS
·
15 minutes ago
Nasdaq rises 1.23% after AI stock sell-off — BBC News
Yahoo Finance
·
1 hour ago
$3 trillion was wiped off the S&P 500 — but it ain't doomsday
TradingView
·
1 hour ago
Dow slides, Nasdaq gains as Wall Street reels from tech selloff
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com